ProtonDX is an innovative start-up on the rise, disrupting the world of POC diagnostics.

The business is going through an exciting growth phase, having successfully secured CE‑IVD marking for its innovative Dragonfly in vitro diagnostic system in 2022.

With Dragonfly at the commercialisation stage, this ambitious start-up is ready to introduce the technology to the European market.

That’s not all. ProtonDx is also developing a futuristic lab-on-a-chip diagnostic tool, Lacewing. This is expected to be the next product that the London start-up brings to market.

Watch our interview with the President, Bob Enck to hear more about ProtonDx's exciting plans.


ProtonDx Products

Developed at Imperial College London, ProtonDx’s products deliver rapid, accurate, portable and low‑cost diagnostics.

Learn More

CM Life Science.

We are a global provider of talent solutions for the life science industry, with a team dedicated to POC diagnostics. We are really excited to partner with ProtonDx for its expansion. If you have any questions about a career with the business, please feel free to contact us.

Have a question? Get in touch here.

Contact Us